LIVIA Group has acquired a 50 % share in Orgatreatments Pvt. Ltd. Co-shareholder is REMONDIS Aqua India Pvt. Ltd., a fully owned subsidiary of REMONDIS Group Germany, a worldwide leading waste-management company. Orgatreatments Pvt. Ltd. owns the factory site and all relevant assets of the state-of-the art bio-composting unit, located in Nanded, Maharashtra, India.
The company’s business focus is the value added processing of citrus waste, supplied by Citrus Processing India Pvt. Ltd. (“CPI”), India’s largest producer of Frozen Concentrate Orange Juice (“FCOJ”). CPI is promoted by Black River Asset Management, PepsiCo, HDFC-Limited and a group of Swiss investors.
”This is a great achievement for LIVIA Emerging Markets AG and we congratulate the parties.“ says H.E. Sevala Naik, Consul General of India in Germany.
The parties agreed to keep details of the investment confidential.
For LIVIA Group this acquisition already represents the fourth corporate investment in the current year. First LIVIA acquired Duisburg Tubes Production AG, a highly specialized producer of zirconium tubes, from the French industrial conglomerate AREVA, followed by the take-over of Italy based Trentinalatte S.p.A., the regional market leader for dairy products, from the Swiss food group Emmi and the 100% takeover of SKW Metallurgie Sweden AB from SKW Metallurgie AG, executed by LIVIA´s affiliate AlzChem AG.
About LIVIA Group
With funds under management amounting to more than € 450m, LIVIA Group is an independent industrial holding company and the family office of Prof Dr Dr Löw, concentrating on a diverse spectrum of assets ranging from corporate, agricultural, emerging markets, real estate, global, and opportunistic investments.
LIVIA Emerging Markets AG is targeting investments with outstanding growth potential in interrelated businesses in the field of infrastructure, natural resources and agriculture, retail and logistics, energy and gas – especially renewable energy. LIVIA Emerging Markets AG combines the investment activities in emerging markets of Prof. Dr. Dr. Löw and Dr. Felix-Michael Weber (Elephant Equity) and is able to invest over € 40 million across a range of companies, projects and assets, including public listed companies.
For more information on the LIVIA Group, please visit www.livia-group.com.